Caixin
Aug 28, 2021 08:00 AM

Beijing Sl Pharmaceutical Co.,Ltd.’s Net Profit Rose 52.6% in First Half of 2021

Beijing Sl Pharmaceutical Co.,Ltd. (北京双鹭药业股份有限公司) (002038.SZ) reported a net profit of 297.6 million yuan in the first half of 2021, up 52.6% year-on-year.

Meanwhile, the company posted 624.5 million yuan in revenue, up 16.3% year-on-year.

At the end of the reporting period, it had 5.7 billion yuan in total assets and 424.5 million yuan in total liabilities, with a liability-to-asset ratio of 7.4%.

This article was automatically produced by Caixin Automation on Sept. 1, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST